Beta

    when fda reclassify bpc-157 category 1

    Before November

    when fda reclassify bpc-157 category 1. Best Yes near 55¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 55¢ · Best No: 55¢ · 1 platform

    • Kalshi: Yes 55¢ / No 55¢
    LIVE

    Before November

    Volume

    $1.7K

    $8 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Nov 1, 2026

    ~138 days left

    Category

    Culture

    55¢CHANCE OF YES50%50%
    Yes
    55¢
    Kalshi
    No
    55¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    KalshiKalshi
    Best Yes
    Best No
    Yes
    55¢
    No
    55¢
    Vol
    $1.7K
    $8 24h
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 55¢: exit costs ~1.73¢/contract
    Full calculator

    Market Details

    ResolutionResolves Nov 1, 2026
    Time Left138 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In